ออฟไลน์ด้วยแอป Player FM !
249 - 20 Years in the Making: REATA's Story of Skyclarys
Manage episode 412609532 series 2030599
This episode delves into the journey of Skyclarys, the first FDA-approved treatment for Friedreich's ataxia (FA), a rare genetic disorder. The discussion features Dr. Colin Meyer, former executive at Reata Pharmaceuticals, who shares his experiences from the inception of Reata to the acquisition by Biogen.
The conversation offers a compelling narrative of resilience, innovation, and collaboration in the pursuit of groundbreaking therapies for rare diseases. Colin's reflections provide valuable perspectives on the challenges and rewards of drug development, as well as the transformative potential of scientific breakthroughs in improving patient outcomes.
Also in this episode:
- Sean visits Golden 1 Arena
- Newsworthy: Athlete With Cerebral Palsy Finishes The Barcelona Marathon
- Thank you notes: Kyle's friends Blake & Dan and Sean's friend Taylor
Links and resources:
287 ตอน
Manage episode 412609532 series 2030599
This episode delves into the journey of Skyclarys, the first FDA-approved treatment for Friedreich's ataxia (FA), a rare genetic disorder. The discussion features Dr. Colin Meyer, former executive at Reata Pharmaceuticals, who shares his experiences from the inception of Reata to the acquisition by Biogen.
The conversation offers a compelling narrative of resilience, innovation, and collaboration in the pursuit of groundbreaking therapies for rare diseases. Colin's reflections provide valuable perspectives on the challenges and rewards of drug development, as well as the transformative potential of scientific breakthroughs in improving patient outcomes.
Also in this episode:
- Sean visits Golden 1 Arena
- Newsworthy: Athlete With Cerebral Palsy Finishes The Barcelona Marathon
- Thank you notes: Kyle's friends Blake & Dan and Sean's friend Taylor
Links and resources:
287 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ